A Marc Lichtenfeld Exclusive Event on Thursday, June 27, at 2 p.m. ET...

Why Nvidia Is Going All-In On This $10 TechBio Stock

And why you should get in before July 1, ahead of the next cash wave

WHEN: THURSDAY, JUNE 27, 2024, at 2:00 P.M. ET

Back to Event Updates

What the Heck Is TechBio Anyway? (A Trillion Dollar Opportunity!)


Dear Reader,

Steve Jobs predicted, “The biggest innovations of the 21st century will be at the intersection of biology and technology. A new era is beginning.”

And we’re starting to see that happen.

Some experts predict that by 2040, generative AI could result in $1 trillion in value for healthcare.

Nvidia’s CEO Jensen Huang said it will be “… the next amazing revolution… It will be one of the biggest ever.”

Those are powerful words coming from someone like him.

But let me be clear, this isn’t just biotech 2.0.

This revolution is so huge and so radical that scientists have come up with an entirely new word for it – TechBio.

It’s more than just a buzzword. It’s a true paradigm shift.

Biotechnology (biotech) typically starts with the biological elements – living organisms, biological molecules, genetic material, etc. – and then applies data analysis, engineering principles, and technology to manipulate or harness those biological components for desired products or outcomes.

TechBio, on the other hand, often begins from an engineering, data science, or technological standpoint. It leverages tools, devices, computational power, and technologies first, which are then applied or integrated with biological systems to study, measure, or interface with those living systems.

TechBio signifies a unique and progressively sophisticated method of drug development.

And it can’t be done without AI.

Thanks to these innovations, we’re starting to see how AI can accelerate the whole process of discovery and testing new compounds. It’s taking a fraction of the time… as much as 15 times faster.

A study by Carnegie Mellon, suggests AI could ultimately cut costs by as much as 70%.

According to the founder and CEO of Nvidia’s favorite biotech, even if they failed 8 times out of 10 in clinical development he said, “we could price all our medicines at half the price of everybody else and still win.”

Mark my words… AI is just the thing that will ignite a massive rally in these stocks. And soon.

But that’s not all…

A PERFECT Storm Is Brewing

As a cherry on top?

Morgan Stanley points out, a Fed rate cut will also fuel these stocks.

“In our view, there have been green shoots pointing to the beginnings of a rally in the Biotech industry,” wrote analysts at Morgan Stanley.

Maybe we didn’t get the rate cut when we wanted or expected it, but one is coming.

And when that happens, look for this corner of the market to really take off.

Why?

Low rates provide a favorable financing environment and increase the valuations of biotech firms’ pipelines, driving outperformance in the sector.

Add it all up, and there’s NEVER been a better time to jump into this market.

On Thursday, you’ll discover the unique way I plan on playing this for potential maximum gains.

Please click the calendar icon below so you can set yourself a reminder.

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

And keep checking our special event page for updates leading up to the big day!

We’re getting really close now. I hope you’re as excited as I am!

Good investing,

Marc

P.S. If you haven’t yet, I urge you again to click here and sign up for free VIP text messaging because it’s such a great resource.

By becoming a VIP, you’ll also receive a complimentary VIP report (valued at $129).

It’s called, “5 Secrets for Investing in the AI Biotech Boom.

You’ll get it instantly.